Top Markets
Coin of the day
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
Rang in Aktien #39234
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Aktienkurs
$0.0045
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$591.52K
Veränderung (1 Tag)
-10.00%
Veränderung (1 Jahr)
-86.76%
Land
US
Handel Burzynski Research Institute, Inc. (BZYR)

Kategorie

Dividendenrendite-Verlauf für Burzynski Research Institute, Inc. (BZYR)
Dividendenrendite (TTM) von Burzynski Research Institute, Inc. (Aktienkürzel: BZYR) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Burzynski Research Institute, Inc. (BZYR) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber